WIA
REGN icon

World Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

World Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$544K Sell
737
-108
-13% -$73.5K 0.01% 929
2026
Q1 		$653K Buy
845
+47
+6% +$36K 0.01% 870
2025
Q4 		$616K Buy
798
+288
+56% +$196K 0.01% 846
2025
Q3 		$287K Sell
510
-39
-7% -$22.1K 0.01% 1004
2025
Q2 		$288K Buy
549
+187
+52% +$104K 0.01% 930
2025
Q1 		$230K Buy
+362
New +$249K 0.01% 964

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

World Investment Advisors's REGN Position: Q2 2026 in Review

World Investment Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 13% in Q2 2026, selling an estimated $73.5K and leaving 737 shares worth $544K. The position accounts for 0.01% of the portfolio, ranked #929.

World Investment Advisors first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $653K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • World Investment Advisors held 737 shares of Regeneron Pharmaceuticals worth $544K as of Q2 2026.
  • World Investment Advisors sold 108 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $73.5K.
  • Regeneron Pharmaceuticals made up 0.01% of World Investment Advisors's portfolio in Q2 2026, its #929 holding.
  • World Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • World Investment Advisors's Regeneron Pharmaceuticals position peaked at $653K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.